L3Harris Technologies reports Q1 2026 results today — April 30 — and the setup heading in is defined by one clear signal: options traders have turned more defensive than they have been in months, even as the short side of the trade remains thin on the ground.
The sharpest read on positioning is the options market. The put/call ratio has climbed to 0.48, more than two standard deviations above its 20-day average of 0.42. That ranks as one of the more elevated defensive readings of the past year for this name — well off the 52-week high of 1.12, but notable for a stock that has spent most of the year with puts and calls roughly balanced. The timing is deliberate: this is earnings-eve hedging, not a structural bearish shift.
Short interest tells a very different story. Bears hold just 1.26% of the free float short — a small position that has been falling steadily, down roughly 4% over the past month to around 2.36 million shares. Borrow cost is essentially negligible at 0.49% APR, and availability in the lending market is ample. The short score of 29 sits comfortably in the lower portion of the range, and the 52-week peak for lending tightness never came close to being a market event. In short, there is no meaningful short-side pressure here — the options hedging and the stock's 3% weekly decline are not a bearish short-seller story.
The Street entered this week broadly constructive. Analyst targets from the major houses — JP Morgan at $395, Morgan Stanley at $390, Citigroup at $418 — were all set in late January and early February, each firm reaffirming positive ratings while lifting numbers after the Q4 print. The consensus mean target of $392 implies more than 20% upside from the current price of $321.40. Worth noting: those upgrades are now nearly three months old, and the stock has since traded down about 12% from the highs, so the gap between target and price reflects compression, not fresh conviction. Valuation has drifted lower with the price — the forward PE has dropped two turns over the past month to 26.2x, and EV/EBITDA has eased to 16.2x. Neither multiple looks stretched for a defense prime. The dividend score ranks in the 95th percentile, though the most recent confirmed dividend data in the ORTEX system dates from 2022, suggesting the current yield calculation should be treated as indicative only.
Among peers, the week was broadly weak for defense names. RTX fell 4.5% and LMT shed more than 8%, making LHX's 3.1% decline look comparatively resilient. The notable outlier was GD, which added nearly 6% on the week — a gap in performance within the sector that likely reflects contrasting earnings reactions rather than divergent fundamentals. KTOS was the hardest hit, down 13%.
On the institutional side, the picture is incrementally constructive. Vanguard and BlackRock added to positions in Q1, with BlackRock building by roughly 791,000 shares. Columbia Management added over a million shares. Insider activity in early March saw two divisional presidents sell around 5,500 shares each — routine-looking sales that came after CEO Christopher Kubasik received a 48,000-share award in late February and sold nearly 19,000 shares on the same day. Nothing in the insider pattern reads as a directional signal.
The previous two earnings prints both produced declines. The January 29 Q4 report sent the stock down 4.8% on the day, and the Q3 report in October 2025 produced an identical reaction. The Q2 result in February 2026 was essentially flat on the day before recovering 4% over the following week. Whether this quarter follows the sell-on-the-day pattern or stages a recovery depends entirely on how management frames margin trajectory in SAS — the segment where analysts already flagged a 30-basis-point year-on-year compression — and whether the Aerojet organic growth story holds.
See the live data behind this article on ORTEX.
Open LHX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
